Study of international experience in the field of industrial safety

2021 ◽  
Vol 83 (1) ◽  
pp. 80-91
Author(s):  
I.I. Kolchenko ◽  
◽  
M.V. Temerbaeva ◽  

Currently, close attention is paid to industrial safety at hazardous production facilities. Compliance with industrial safety requirements is directly related to the risks of accidents that can lead to man-made disasters, negatively affect the health and life of the population. As in any other industry, there are problems in ensuring industrial safety. There are several reasons for this: the backlog of standards from scientific and technological progress, the exclusive competence of state authorized bodies, and the lack of a risk-based approach. After the collapse of the USSR, the requirements of industrial safety in the Republic of Kazakhstan have practically not changed: laws and statutory instruments (hereinafter-the LSI) are approved and put into effect, after which they are constantly changed and supplemented; the presence of national and international standards, which, in fact, are revised on the basis of the USSR standards, taking into account the influence of the realities of the time. It can be concluded that the current standards are not focused on the future, scientific and technological progress, innovation, so they are constantly undergoing changes, thereby adapting to the necessary requirements that dictate modernity. State regulation does not contribute to the effective development of industrial safety. This is due to the fact that the state performs exclusively supervisory functions (thus it is exclusively educational in nature), and there is no dialogue between authorized state bodies, expert organizations, scientific organizations, and testing laboratories. If we consider the experience of the Russian Federation in the field of industrial safety, then it makes no sense to accept even some experience, since: similar to the Kazakhstan’ LSI and regulatory and technical documentation (and their constant dynamics), the development of cooperation with the Russian Federation within the framework of the Eurasian Economic Union. Accordingly, it is advisable to consider the experience in the field of industrial safety in Europe and the United States of America because of the effectiveness of regulation and supervision than in the Republic of Kazakhstan and the Russian Federation. This article provides information about international experience in the field of industrial safety in the United States and the European Union. The tasks of state regulation in the field of industrial safety in the Republic of Kazakhstan, the Russian Federation, the United States, and the European Union are described in detail. The analysis of normative-legal acts and normative-technical documentation is carried out. Based on the analysis of international experience, solutions to problems in the field of industrial safety for the Republic of Kazakhstan are essentially presented. The purpose of this article is to reveal the problem in the field of industrial safety in the Republic of Kazakhstan and international experience that the Republic of Kazakhstan can borrow in order to effectively ensure industrial safety. Study of international experience (USA, EU countries, Russia) in the field of industrial safety in terms of: analysis of standards; regulation (control and supervisory functions) to ensure safety. The results of this article will reflect the problems that hinder the effective provision of industrial safety in the Republic of Kazakhstan and essentially suggest ways to solve them.

Author(s):  
Alexander Chaplenko ◽  
Geliya Gildeeva ◽  
Vasiliy Vlassov

Objective: Evaluation of the lag timelines for the launch of innovative drugs to the Russian market and pharmacoeconomic factors they can depend on. Methods: To complete the investigation, we used information about drug products, namely, dates of submission and approval, and pharmacological groups recovered from national registers and official databases. Results: Due to impacts of market factors and imperfection of the state regulation, original drugs developed abroad enter the Russian market a few years after their registration in the United States of America, the European Union, and Japan. The average time from the moment of initial approval of a drug in the aforementioned countries and jurisdictions to the moment of registration in Russia is 4 years and 8 months, with a median value of 2.5 years. It has been shown that half of this term is spent on the performance of the procedures of the expertise of the drug registration dossier in the Russian Federation. Conclusion: To attain the goal of adequate supplies to the population of the Russian Federation of the most up-to-date, high quality, safe, and efficacious medications, apart from the support of national originators of innovative drugs, we are required to upgrade the existing system of original drug registration. Improvement should be primary focused on the drugs already approved by the leading national regulatory authorities in order to ensure innovative medicine access for Russian patients.


Author(s):  
L.A. Bukalerova ◽  
◽  
A.V. Ostroushko ◽  
M.B. Muratkhanova ◽  
A.A. Bukalerov ◽  
...  

2017 ◽  
Vol 11 (3-4) ◽  
pp. 105-111 ◽  
Author(s):  
István Szűcs ◽  
Viktoria Vida

World meat production is anticipated to stagnate in 2016, rising by a mere 0.3% to 320.7 million tonnes. Increases in output are expected in the United States, Brazil, the EU, India and the Russian Federation, while reduced production is foreseen for China, Australia and South Africa. Global meat trade is forecast to recover in 2016, growing by 2.8% to 30.6 million tonnes, which would represent a return to trend, after a fall in 2015. World production of pig meat in 2016 is forecast to decrease marginally, by 0.7% to 116.4 million tonnes, thus registering a second year of virtual stagnation. As in 2015, lower output in China, which accounts for almost half the world total, is the main reason for the slowdown. An unfavourable feed-pork price ratio in the country and new environmental regulations have caused farmers to reduce breeding sows, stalling growth. China’s production is projected to be 54 million tonnes, down 2.5% from the previous year. Elsewhere in Asia, the Philippines and Vietnam could boost output. Also, production in Japan and the Republic of Korea may expand, as the industry recovers from outbreaks of PED, which reduced piglet numbers in the previous two years. Recovery from the effects of PED has been faster in the United States, where a second year of growth is anticipated, when production could increase by 1.9% to a record 11.3 million tonnes. Output in Mexico also continues to recover, following a PED outbreak in 2014, and may rise in 2016 by 2.0% to 1.3 million tonnes. Pork meat trade could experience a second year of growth, increasing by 4.4% to 7.5 million tonnes – a record level. Lower international prices have stimulated trade. Most of the principal importing countries are anticipated to increase their purchases, including Mexico, China, the Russian Federation, the United States, Japan, the Republic of Korea and Australia. In response to rising demand, exports are projected to grow, in particular those of the United States, Canada, the EU and Brazil (FAO, 2016). Summarizing, in this study we wish to examine how evolve the world pork meat production, trade and consumption, and to demonstrate the main consuming countries, highlighting the role of China, as it is the most populated country in the world with its 1.4 billion inhabitants. JEL Code: Q13, Q12


Author(s):  
Sergei Valer'evich Krivov ◽  
Tat'yana Vladimirovna Baranova ◽  
Sergey Valer'evich Starkin

The subject of this research is the sanctions imposed by Western countries against Russia in response to the Ukrainian events of 2014. Leaning on the available empirical data and expert assessments conducted by various financial and analytical structures, an attempt is made to identify the nature and severity of impact of sanction pressure upon different economic sectors of the Russian Federation, implemented for achieving the foreign policy goals. Emphasis is placed on the absence of uniform sanctions policy due to the specificity of foreign policy goals and peculiarities of sanction mechanisms used by the United States and the European Union. It is underlined that anti-Russian sanctions and Russia’s response in many instances are substantiated by the preceding trends in strategic vision of foreign and domestic policy by the Russian Federation, as well as the nature of its relations with the West. The conclusion is made that the focus in studying the problem of sanctions has shifted towards the political analysis and further analytical and scientific examination. The author believes that in the conditions of uncertainty of the economic effects and absence of common approaches towards understanding the prospects of sanctions policy by the Western countries the two main scenarios of its further development. It would either gradually fade out without “renewed efforts”, slowly negating its practical effect, and prompt the United States and the European Union intensify the dialogue with Russia, avoiding the problematic issues on the status of Crimea, implication in the events in South-Eastern Ukraine, etc.; or it can lead to full “politicization” of sanctions polity and its integration into the negotiation process on settlement of the Ukrainian situation and turning into a powerful tool for conducting negotiations.


Author(s):  
A. Ersh

In this article the concept of the venture capital is invest-gated and its role in the system of innovative business is examined. The mechanism of venture investment is established. The features of venture financing have been determined. The article also analyzes the experience of state support for venture entrepreneurship on the example of Japan, China, Israel, the United States and the Russian Federation. Recommendations are given on the creation of a system of tax preferences in the Republic of Belarus to stimulate venture capital investments.


2021 ◽  
Vol 1 (1) ◽  
pp. 92-103
Author(s):  
V. A. Martinovich

This paper is devoted to the analysis of the influence of the new religious movements of the Russian Federation on the religious landscape of the Republic of Belarus. The study has shown the following results: (1) the country of origin was determined for the alleged general population of 1113 new religious movements, the activities of which are documented in the Republic of Belarus. A significant part of them were founded in Russia, and the group of Russian new religious movements is in the lead among the foreign new religious movements almost twice exceeding the group of new religious movements created in Western countries. (2) The article represents the distribution according to the structural and substantive characteristics of the new Russian religious movements operating in the Republic of Belarus in comparison with the totality of new religious movements created in the United States and (3) shows the dynamics of migration of Russian new religious movements to Belarus. (4) Based on the analysis of Belarusian print media the main indicators of advertising and criticism of Russian and Western new religious movements are revealed. To represent the research results the author uses a matrix of non-traditional religiosity as tool for monitoring, recording and visualizing the whole variety of its forms and varieties for a specific area in a given period of time. In conclusion, the author proposes a number of promising directions for further analysis of the stated topic.


2021 ◽  
Vol 65 (3) ◽  
pp. 269-275
Author(s):  
Diana A. Lebedeva

Introduction. When patenting pharmaceutical innovations, in the context of rapid technological progress, pharmaceutical companies often have to face identifying patentable objects both in the Russian Federation and in the United States of America and the European Union. The aim of the study is to review the possibilities for patenting pharmaceutical innovations in the Russian Federation, the United States of America and the European Union, as well as to identify the advantages and disadvantages of legal regulation of innovative solutions of pharmaceutical companies in the context of the specifics of legal systems. Material and methods. The national legislation in patenting medical innovations was studied, and the relevant experience of the USA and the European Union was analyzed. The methodological basis of the research is made up of both general scientific and private scientific legal methods: systemic, method of concretization, methods of synthesis and analysis, as well as the comparative-legal method. Results. Depending on the legislator’s position, a basis is being formed for the legal regulation of innovative solutions of pharmaceutical companies, which may not yet be named in regulatory legal acts due to their fundamental novelty. Legal gaps and conflicts in the US and the EU are resolved through in-depth analysis and consideration of each specific dispute by the court. In Russia, the settlement of this issue is on the way to solving it through local regulations and the position of the relevant federal executive bodies. Conclusion. Patenting in the pharmaceutical field is mainly of a stimulating nature, since it allows protecting innovative solutions at the stage of their development. However, the legislator has particular difficulties in identifying patentable objects in the context of rapid technological progress.


Sign in / Sign up

Export Citation Format

Share Document